Sign In
Buy ERFSF
$70.54
-1.96 (-2.71%)
At Close: Jun 22, 2026
Eurofins Scientific: Strong Cash Flows Will Fund M&A To Boost EBITDA Growth
10:30am, Thursday, 09'th Jan 2025
Eurofins Scientific's EBITDA fell post COVID, but growth is expected to resume with aggressive targets, making the stock appealing despite recent setbacks. The company confirmed its 2024 outlook, expe
Eurofins Scientific SE (ERFSF) Q3 2024 Earnings Call Transcript
02:14pm, Tuesday, 22'nd Oct 2024
Eurofins Scientific SE (OTCPK:ERFSF) Q3 2024 Results Conference Call October 22, 2024 9:00 AM ET Company Participants Dr. Gilles Martin - Chief Executive Officer Laurent Lebras - Chief Financial Offic
Eurofins Scientific: On Track To Generate 1.5B EUR In EBITDA
10:30am, Thursday, 12'th Sep 2024
Eurofins Scientific faced a short attack by Muddy Waters but has since recovered, maintaining strong financials and cash flow despite the initial share price drop. The company reported a net profit of
All You Need to Know About EUROFINS SCIENT (ERFSF) Rating Upgrade to Buy
01:00pm, Tuesday, 30'th Jul 2024
EUROFINS SCIENT (ERFSF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Eurofins Scientific SE (ERFSF) Q2 2024 Earnings Call Transcript
01:06pm, Wednesday, 24'th Jul 2024
Eurofins Scientific SE (OTCPK:ERFSF) Q2 2024 Earnings Call July 24, 2024 9:00 AM ET Company Participants Gilles Martin - Chief Executive Officer Laurent Lebras - Chief Financial Officer Conference Cal
Eurofins Scientific's stock drops on allegations from short-seller Muddy Waters
08:32am, Monday, 24'th Jun 2024
Eurofins Scientific shares plunged on Monday after Muddy Waters Research said in a report it had started shorting the laboratory-services company, alleging founder and Chief Executive Gilles Martin ha
Eurofins Scientific SE (ERFSF) Q1 2024 Earnings Call Transcript
03:52pm, Wednesday, 24'th Apr 2024
Eurofins Scientific SE (OTCPK:ERFSF) Q1 2024 Earnings Conference Call April 24, 2024 9:00 AM ET Company Participants Gilles Martin - Chairman and CEO Conference Call Participants Suhasini Varanasi - G
EUROFINS SCIENT (ERFSF) Upgraded to Buy: What Does It Mean for the Stock?
01:01pm, Friday, 08'th Mar 2024
EUROFINS SCIENT (ERFSF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Eurofins Scientific Is A Growth Story That Has Reached Fair Valuation Again
03:06pm, Thursday, 01'st Feb 2024
Eurofins Scientific is delivering a 10% growth without relying on exuberant COVID-related margins. The company boasts a robust business model, a significant market share, and a reliable and trustworth
Eurofins Scientific SE (ERFSF) Q3 2023 Earnings Call Transcript
12:10pm, Tuesday, 24'th Oct 2023
Eurofins Scientific SE (OTCPK:ERFSF) Q3 2023 Earnings Conference Call October 24, 2023 9:00 AM ET Company Participants Gilles Martin - Chairman and Chief Executive Officer Conference Call Participants
Eurofins Scientific: The Normalization Of COVID-Related Sales Presents An Opportunity
12:26pm, Friday, 20'th Oct 2023
Eurofins Scientific: The Normalization Of COVID-Related Sales Presents An Opportunity
Eurofins Scientific Still Plans To More Than Double Its FCF By 2027
10:40am, Saturday, 05'th Aug 2023
Eurofins is dealing with a revenue decrease due to the lack of COVID testing and the sale of reagents. Excluding the COVID-related revenue, the H1 2023 revenue would have increased by a high single di
Introduction To The Testing, Inspection, And Certification (TIC) Market
12:13pm, Friday, 31'st Mar 2023
We present an overview of the testing, inspection, and certification (TIC) market. We highlight the different strategies that have been pursued by the main 4 players over time.
Eurofins Scientific SE (ERFSF) Q4 2022 Earnings Call Transcript
05:00pm, Friday, 03'rd Mar 2023
Eurofins Scientific SE (OTCPK:ERFSF) Q4 2022 Results Conference Call March 1, 2023 9:00 AM ET Company Participants Dr. Gilles Martin - Chairman and Chief Executive Officer Laurent Lebras - Chief Finan
Eurofins Scientific: A Buy On Any Further Pullback
11:35am, Saturday, 14'th Jan 2023
Eurofins Scientific printed cash during the COVID pandemic as its testing capacity was running at full utilization. There shouldn't be any massive post-COVID blues as growth in other domains should of
